Incidence rate and time to serious adverse events among rifampicin resistant tuberculosis patients in Georgia treated with new and repurposed anti-tuberculosis drugs, 2016–2018

por Buziashvili, Mariana, Davtyan, Hayk, Sereda, Yuliia, Denisiuk, Olga, Gozalov, Ogtay, Lomtadze, Nino, Hovhannesyan, Arax
Publicado 2021

Xpert MTB/RIF Use Is Associated With Earlier Treatment Initiation and Culture Conversion Among Patients With Sputum Smear-Negative Multidrug-Resistant Tuberculosis

por Kipiani, Maia, Graciaa, Daniel S, Buziashvili, Mariana, Darchia, Lasha, Avaliani, Zaza, Tabagari, Nino, Mirtskhulava, Veriko, Kempker, Russell R
Publicado 2021

Diagnostic Procedures, Diagnoses, and Treatment Outcomes of Patients with Presumptive Tuberculosis Pleural Effusion in Uzbekistan

por Abdugapparov, Fazlkhan, Grigoryan, Ruzanna, Parpieva, Nargiza, Massavirov, Sherali, Riskiyev, Anvar, Gadoev, Jamshid, Buziashvili, Mariana, Tukvadze, Nestani, Hovhannesyan, Arax, Dadu, Andrei
Publicado 2021

Incidence Rate and Risk Factors for Tuberculosis among People Living with HIV: A 2015–2017 Cohort from Tashkent, Uzbekistan

por Sadirova, Dilbar, Grigoryan, Ruzanna, Parpieva, Nargiza, Barotova, Venera, Trubnikov, Aleksandr, Kalandarova, Lola, Gadoev, Jamshid, Mukhtarov, Davron, Buziashvili, Mariana, Tukvadze, Nestani, Hovhannesyan, Arax, Dadu, Andrei
Publicado 2021